Macro and Micro Level Usage of Outcomes Research in Pharmacy Practices

Aday A. , Begley C. , Lairson D. , Balkrishnan R. Evaluating the Healthcare System: Effectiveness, Efficiency, and Equity. 3rd ed. Chicago, IL: Health Administration Press; 2004.

Kane R. Understanding Health Care Outcomes Research. Sudbury, MA: Jones & Bartlett; 1997.

MacKinnon G. Understanding Health Outcomes and Pharmacoeconomics. Subury, MA: Jones & Bartlett Publishers; 2013.

Drummond M. , Schwarts J. , Jonsson B. Key principles for the improved conduct of health technology assessments for resource allocation decisions. Int J Technol Assess Health Care. 2008; 24(3): 244–258.

ASHP Guidelines on the Pharmacy and Therapeutics Committee and the Formulary System. http://www.ashp.org/doclibrary/bestpractices/formgdlptcommformsyst.pdf. Accessed August 27, 2015.

Neumann P. Communicating and promoting comparative effectiveness research findings. New Engl J Med. 2013; 369(3): 209–211.

Schumock G. , Pickard A. Comparative effectiveness research: Relevance and applications to pharmacy. Am J Health Syst Pharm. 2009; 66(14): 1278–1286.

Patel H. , Toe D.C. , Burke S. , Rasu R.S. Anticonvulsant use after formulary status change for brand-name second-generation anticonvulsants. Am J Manag Care. 2010; 16(8): e197–204.

Sullivan S.D. , Yeung K. , Vogeler C. Design, implementation, and first-year outcomes of a value-based drug formulary. J Manag Care Specialty Pharm. 2015; 21(4): 269–275.

Iezzoni L.I. Reasons for risk adjustment. In: Iezzoni L.I. , ed. Risk Adjustment for Measuring Healthcare Outcomes. 3rd ed. Chicago, IL: Health Administration Press; 2003.

Berger M. , Mamdani M. , Atkin D. , Johnson M. Good research practices for comparative effectiveness research: Defining, reporting and interpreting nonrandomized studies of treatment effects using secondary data sources: The ISPOR Good Research Practices for Retrospective Database Analysis Task Force Report—Part I, value in health. 2009; 12(8): 1044–1052.

http://www.ispor.org/TaskForces/documents/RDPartI.pdf. Accessed September 4, 2015.

Doi S. , Barendreqt J. , Rao C. An updated method for risk adjustment in outcomes research. Value in Health. 2014; 17(5): 629–633.

International Society for Pharmacoeconomics and Outcomes Research. http://www.ispor.org/. Accessed August 27, 2015.

Academy of Managed Care Pharmacy. http://www.amcp.org/. Accessed August 27, 2015.

American Society of Health-System Pharmacists. http://www.ashp.org/. Accessed August 27, 2015.

American Pharmacist Association. http://www.pharmacist.com/. Accessed August 27, 2015.

American Association of Colleges of Pharmacy. http://www.aacp.org/. Accessed August 27, 2015.

International Pharmaceutical Federation (FIP). http://f.lip.org/. Accessed December 11, 2015. ■